Haprolid inhibits tumor growth of hepatocellular carcinoma through Rb/E2F and Akt/mTOR inhibition

to connected objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
In: Xing, J.; Bhuria, V.; Bui, K.C.; Nguyen, M.L.T.; Hu, Z. et al.: Haprolid inhibits tumor growth of hepatocellular carcinoma through Rb/E2F and Akt/mTOR inhibition. In: Cancers 12 (2020), Nr. 3, 615. DOI: https://doi.org/10.3390/cancers12030615

Event
Veröffentlichung
(where)
Hannover
(who)
Gottfried Wilhelm Leibniz Universität Hannover
(when)
2020
Event
Veröffentlichung
(where)
Hannover
(who)
Technische Informationsbibliothek (TIB)
(when)
2020
Creator
Xing, Jun
Bhuria, Vikas
Bui, Khac Cuong
Nguyen, Mai Ly Thi
Hu, Zexi
Hsieh, Chih-Jen
Wittstein, Kathrin
Stadler, Marc
Wilkens, Ludwig
Li, Jun
Kalesse, Markus
Bozko, Przemyslaw
Plentz, Ruben R.

DOI
10.15488/10856
URN
urn:nbn:de:101:1-2021051302264402786302
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
25.03.2025, 1:44 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Xing, Jun
  • Bhuria, Vikas
  • Bui, Khac Cuong
  • Nguyen, Mai Ly Thi
  • Hu, Zexi
  • Hsieh, Chih-Jen
  • Wittstein, Kathrin
  • Stadler, Marc
  • Wilkens, Ludwig
  • Li, Jun
  • Kalesse, Markus
  • Bozko, Przemyslaw
  • Plentz, Ruben R.
  • Gottfried Wilhelm Leibniz Universität Hannover
  • Technische Informationsbibliothek (TIB)

Time of origin

  • 2020

Other Objects (12)

Haprolid inhibits tumor growth of hepatocellular carcinoma through Rb/E2F and Akt/mTOR inhibition

Haprolid inhibits tumor growth of hepatocellular carcinoma through Rb/E2F and Akt/mTOR inhibition

Glycine - tumor growth inhibition in experimental hepatocellular carcinoma

Hochschulschrift

Glycine - tumor growth inhibition in experimental hepatocellular carcinoma

Subclinical hepatocellular carcinoma

Subclinical hepatocellular carcinoma

Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells

Hochschulschrift

Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells

Water-soluble pristine C60 fullerene inhibits liver alterations associated with hepatocellular carcinoma in rat

Water-soluble pristine C60 fullerene inhibits liver alterations associated with hepatocellular carcinoma in rat

Could NAMPT inhibition become a potential treatment option in hepatocellular carcinoma?

Could NAMPT inhibition become a potential treatment option in hepatocellular carcinoma?

Sorafenib response in hepatocellular carcinoma therapy : introducing new possibilities with Cdk5 inhibition

Sorafenib response in hepatocellular carcinoma therapy : introducing new possibilities with Cdk5 inhibition

Progress in hepatocellular carcinoma treatment

Konferenzschrift | Kongress

Progress in hepatocellular carcinoma treatment

Targeting FUBP1 in Hepatocellular Carcinoma

Hochschulschrift

Targeting FUBP1 in Hepatocellular Carcinoma

Targeting FUBP1 in hepatocellular carcinoma

Hochschulschrift

Targeting FUBP1 in hepatocellular carcinoma

Pathogenesis of human hepatocellular carcinoma

Aufsatzsammlung

Pathogenesis of human hepatocellular carcinoma

Multidisciplinary treatment of hepatocellular carcinoma

Aufsatzsammlung

Multidisciplinary treatment of hepatocellular carcinoma

Related objects